University of Colorado Advanced Reproductive Medicine researchers uncover a relationship between omega-3 fatty acids and increased ovarian reserve that could benefit up to 30 percent of infertile women.
Expanding insurance coverage for elective single-embryo transfer during IVF could lead to improved health outcomes and lower health care costs, according to a new study by Dr. Alex Polotsky of the University of Colorado’s Advanced Reproductive Medicine.
The Reproductive Medicine Network study highlights an important discovery in treatment of women’s infertility including the benefits of using the drug letrozole to stimulate ovulation and reduce multiple births, instead of other drugs currently used as standard therapy.
The National Institutes of Health (NIH) has awarded CU Advanced Reproductive Medicine a $1.7 million grant to investigate how follicle stimulating hormone (FSH) releases and interacts with ovaries in obese women. FSH, regulates egg production in the ovaries and is a key factor in determining a woman’s fertility.
The University of Colorado Fertility and Engineering departments have created a first-of-its-kind passive dilation seat for women with vaginal agenesis.
Alex Polotsky, M.D., has been appointed interim chief of the Advanced Reproductive Medicine division at the University of Colorado Denver.
CU proves that males who smoke while trying to conceive when their female partner has polycystic ovary syndrome (PCOS) have a harder time getting pregnant.
Couples of Hispanic and Latin American heritage with fertility problems are half as likely as the overall U.S. population to seek infertility treatment, a situation CU’s Advanced Reproductive Medicine wants to change.
University of Colorado Advanced Reproductive Medicine worked four years on an NIH study to determine the best treatment for an estimated 30 percent of infertility patients.